155 related articles for article (PubMed ID: 16778122)
1. Dysregulation of the ubiquitin-proteasome system in human carotid atherosclerosis.
Versari D; Herrmann J; Gössl M; Mannheim D; Sattler K; Meyer FB; Lerman LO; Lerman A
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2132-9. PubMed ID: 16778122
[TBL] [Abstract][Full Text] [Related]
2. Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity.
Marfella R; Siniscalchi M; Portoghese M; Di Filippo C; Ferraraccio F; Schiattarella C; Crescenzi B; Sangiuolo P; Ferraro G; Siciliano S; Cinone F; Mazzarella G; Martis S; Verza M; Coppola L; Rossi F; D'Amico M; Paolisso G
Hypertension; 2007 Apr; 49(4):784-91. PubMed ID: 17309948
[TBL] [Abstract][Full Text] [Related]
3. Association between 5-lipoxygenase expression and plaque instability in humans.
Cipollone F; Mezzetti A; Fazia ML; Cuccurullo C; Iezzi A; Ucchino S; Spigonardo F; Bucci M; Cuccurullo F; Prescott SM; Stafforini DM
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1665-70. PubMed ID: 15933245
[TBL] [Abstract][Full Text] [Related]
4. Proteasome activity as a target of hormone replacement therapy-dependent plaque stabilization in postmenopausal women.
Marfella R; Di Filippo C; Portoghese M; Ferraraccio F; Crescenzi B; Siniscalchi M; Barbieri M; Bologna C; Rizzo MR; Rossi F; D'Amico M; Paolisso G
Hypertension; 2008 Apr; 51(4):1135-41. PubMed ID: 18259030
[TBL] [Abstract][Full Text] [Related]
5. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment.
Marfella R; D'Amico M; Di Filippo C; Baldi A; Siniscalchi M; Sasso FC; Portoghese M; Carbonara O; Crescenzi B; Sangiuolo P; Nicoletti GF; Rossiello R; Ferraraccio F; Cacciapuoti F; Verza M; Coppola L; Rossi F; Paolisso G
J Am Coll Cardiol; 2006 Jun; 47(12):2444-55. PubMed ID: 16781372
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress upregulates ubiquitin proteasome pathway in retinal endothelial cells.
Fernandes R; Ramalho J; Pereira P
Mol Vis; 2006 Dec; 12():1526-35. PubMed ID: 17167411
[TBL] [Abstract][Full Text] [Related]
7. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization.
Peeters W; Hellings WE; de Kleijn DP; de Vries JP; Moll FL; Vink A; Pasterkamp G
Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):128-33. PubMed ID: 18931283
[TBL] [Abstract][Full Text] [Related]
8. High expression of ubiquitin conjugates and NF-κB in unstable human intracranial atherosclerotic plaques.
Sun R; Xiao L; Duan S
J Cell Physiol; 2012 Feb; 227(2):784-8. PubMed ID: 21503877
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization.
Dahl TB; Yndestad A; Skjelland M; Øie E; Dahl A; Michelsen A; Damås JK; Tunheim SH; Ueland T; Smith C; Bendz B; Tonstad S; Gullestad L; Frøland SS; Krohg-Sørensen K; Russell D; Aukrust P; Halvorsen B
Circulation; 2007 Feb; 115(8):972-80. PubMed ID: 17283255
[TBL] [Abstract][Full Text] [Related]
10. The effect of CYP2E1-dependent oxidant stress on activity of proteasomes in HepG2 cells.
Kessova IG; Cederbaum AI
J Pharmacol Exp Ther; 2005 Oct; 315(1):304-12. PubMed ID: 16002458
[TBL] [Abstract][Full Text] [Related]
11. Chronic proteasome inhibition contributes to coronary atherosclerosis.
Herrmann J; Saguner AM; Versari D; Peterson TE; Chade A; Olson M; Lerman LO; Lerman A
Circ Res; 2007 Oct; 101(9):865-74. PubMed ID: 17823377
[TBL] [Abstract][Full Text] [Related]
12. Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis.
Vandenberghe I; Créancier L; Vispé S; Annereau JP; Barret JM; Pouny I; Samson A; Aussagues Y; Massiot G; Ausseil F; Bailly C; Kruczynski A
Biochem Pharmacol; 2008 Aug; 76(4):453-62. PubMed ID: 18577376
[TBL] [Abstract][Full Text] [Related]
13. The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases.
Wang J; Maldonado MA
Cell Mol Immunol; 2006 Aug; 3(4):255-61. PubMed ID: 16978533
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy.
Bahrudin U; Morisaki H; Morisaki T; Ninomiya H; Higaki K; Nanba E; Igawa O; Takashima S; Mizuta E; Miake J; Yamamoto Y; Shirayoshi Y; Kitakaze M; Carrier L; Hisatome I
J Mol Biol; 2008 Dec; 384(4):896-907. PubMed ID: 18929575
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment.
Marfella R; D'Amico M; Esposito K; Baldi A; Di Filippo C; Siniscalchi M; Sasso FC; Portoghese M; Cirillo F; Cacciapuoti F; Carbonara O; Crescenzi B; Baldi F; Ceriello A; Nicoletti GF; D'Andrea F; Verza M; Coppola L; Rossi F; Giugliano D
Diabetes; 2006 Mar; 55(3):622-32. PubMed ID: 16505224
[TBL] [Abstract][Full Text] [Related]
16. Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9: implications for human atherosclerosis.
Zalba G; Fortuño A; Orbe J; San José G; Moreno MU; Belzunce M; Rodríguez JA; Beloqui O; Páramo JA; Díez J
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):587-93. PubMed ID: 17194891
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibition up-regulates p53 and apoptosis-inducing factor in chondrocytes causing severe growth retardation in mice.
Zaman F; Menendez-Benito V; Eriksson E; Chagin AS; Takigawa M; Fadeel B; Dantuma NP; Chrysis D; Sävendahl L
Cancer Res; 2007 Oct; 67(20):10078-86. PubMed ID: 17942942
[TBL] [Abstract][Full Text] [Related]
18. Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice.
Tsukamoto O; Minamino T; Okada K; Shintani Y; Takashima S; Kato H; Liao Y; Okazaki H; Asai M; Hirata A; Fujita M; Asano Y; Yamazaki S; Asanuma H; Hori M; Kitakaze M
Biochem Biophys Res Commun; 2006 Feb; 340(4):1125-33. PubMed ID: 16403436
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques.
Mannheim D; Herrmann J; Versari D; Gössl M; Meyer FB; McConnell JP; Lerman LO; Lerman A
Stroke; 2008 May; 39(5):1448-55. PubMed ID: 18356547
[TBL] [Abstract][Full Text] [Related]
20. Exposure of Lemna minor to arsenite: expression levels of the components and intermediates of the ubiquitin/proteasome pathway.
Santos C; Gaspar M; Caeiro A; Branco-Price C; Teixeira A; Ferreira RB
Plant Cell Physiol; 2006 Sep; 47(9):1262-73. PubMed ID: 16926164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
